Compound, process for preparing same, pharmaceutical composition, process for preparing same, use of a compound, and method for treating or reducing the risk of a disease or condition.
JOHAN BYLUND,MARIA E. EK,YLVA GRAVENFORS,JÖRG HOLENZ,ALEXANDER MINIDIS,GUNNAR NORDVALL,DANIEL SOHN,KARL S. A. VALLIN,JENNY VIKLUND,STEFAN VON BERG
申请号：
BRPI0821299
公开号：
BRPI0821299A2
申请日:
2008.12.18
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
The invention provides compounds of formula (I) wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof； together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.
